These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2696465)
1. [Physicochemical and toxicologic aspects of partial glycerides as carrier systems for transdermal systems]. Heers W Arzneimittelforschung; 1989 Nov; 39(11A):1491-4. PubMed ID: 2696465 [TBL] [Abstract][Full Text] [Related]
2. Rationale and applications of lipids as prodrug carriers. Lambert DM Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S15-27. PubMed ID: 11033424 [TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier. Charoenputtakhun P; Opanasopit P; Rojanarata T; Ngawhirunpat T Pharm Dev Technol; 2014 Mar; 19(2):164-72. PubMed ID: 23356887 [TBL] [Abstract][Full Text] [Related]
4. Vesicular system: Versatile carrier for transdermal delivery of bioactives. Singh D; Pradhan M; Nag M; Singh MR Artif Cells Nanomed Biotechnol; 2015; 43(4):282-90. PubMed ID: 24564350 [TBL] [Abstract][Full Text] [Related]
5. Microemulsions as transdermal drug delivery vehicles. Kogan A; Garti N Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of transdermal property in vitro of different breviscapine lipid carrier gels]. Xiong X; Xu JY; Yin XQ; Chen YJ Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3554-7. PubMed ID: 23477138 [TBL] [Abstract][Full Text] [Related]
7. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Lauterbach A; Müller-Goymann CC Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664 [TBL] [Abstract][Full Text] [Related]
8. Vesicular carriers for dermal drug delivery. Sinico C; Fadda AM Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979 [TBL] [Abstract][Full Text] [Related]
11. Transdermal drug delivery: problems and possibilities. Knepp VM; Hadgraft J; Guy RH Crit Rev Ther Drug Carrier Syst; 1987; 4(1):13-37. PubMed ID: 3315235 [TBL] [Abstract][Full Text] [Related]
12. Stability of a liposomal formulation containing lipoyl or dihydrolipoyl acylglycerides. Laszlo JA; Evans KO; Compton DL J Liposome Res; 2014 Dec; 24(4):304-12. PubMed ID: 24646435 [TBL] [Abstract][Full Text] [Related]
13. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Baek JS; Pham CV; Myung CS; Cho CW Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems. Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657 [TBL] [Abstract][Full Text] [Related]
15. The production of bactericidal fatty acids from glycerides in staphylococcal abscesses. Shryock TR; Kapral FA J Med Microbiol; 1992 Apr; 36(4):288-92. PubMed ID: 1560451 [TBL] [Abstract][Full Text] [Related]
16. [The effect of lipophilicity of drugs and the construction principles of transdermal plasters containing beta-blockers on blood levels in animals]. Dittgen M; Adam H; Przylucki K; Baumann A Pharmazie; 1991 Aug; 46(8):608-9. PubMed ID: 1686805 [No Abstract] [Full Text] [Related]
17. Physicochemical, physiological, and mathematical considerations in optimizing percutaneous absorption of drugs. Siddiqui O Crit Rev Ther Drug Carrier Syst; 1989; 6(1):1-38. PubMed ID: 2665947 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers. Lopes LB; Murphy N; Nornoo A Pharm Dev Technol; 2009; 14(5):524-9. PubMed ID: 19552564 [TBL] [Abstract][Full Text] [Related]
19. Lipid vesicles and other colloids as drug carriers on the skin. Cevc G Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752 [TBL] [Abstract][Full Text] [Related]
20. [Relation between molecular structure and inhibiting effect of fatty acids and monoglycerides on the respiratory chain of mitochondrial particles]. Schewe T; Coutelle C; Rapoport S Acta Biol Med Ger; 1971; 27(1):13-28. PubMed ID: 5147425 [No Abstract] [Full Text] [Related] [Next] [New Search]